Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase I Study of HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies

NCT03906643 is registered in ClinicalTrials.gov with Herbert Lyerly as lead sponsor.

NCT NCT03906643
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03906643 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase I Study of HS-201, an HSP90 Inhibitor-linked Verteporfin for Detection of Solid Malignancies
Lead sponsor
Herbert Lyerly
Phase
Phase 1
Overall status
Withdrawn
Start date
July 15, 2020
Completion date
February 20, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

solid tumor